Article · August 31, 2021
J&J: Potential HIV vaccine falls short in mid-stage study
A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday. J&J plans to end that study, which involved young women in sub-…